Company Profile

PHARMAIDS PHARMACEUTICALS LTD.

NSE : NABSE : 524572ISIN CODE : INE117D01018Industry : TradingHouse : Private
BSE16.58-0.69 (-4 % )
PREV CLOSE (Rs.) 17.27
OPEN PRICE (Rs.) 17.27
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 4360
TODAY'S LOW / HIGH (Rs.)16.41 17.27
52 WK LOW / HIGH (Rs.) 9.02 30.4
NSE
This Company is not listed in NSE

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.72289
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) NA
ROCE (%) -4.45
Incorporation Year : 1989

Management Info :

- Chairman - Managing Director

Registered Office :

Address : 4-4-211/212/3,1st Floor,sultan Bazar,Inderbagh,
Hyderabad,
Telangana-500095

Phone : 040-40122151

Website : www.pharmaids.com

Registrar's Details : Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE
NEWS More
12Oct10-12-2021$ Clarification sought from Pharmaids Pharmaceuticals Ltd Clarification sought from P
The Exchange has sought clarification from Pharmaids Pharmaceuticals Ltd on October 12, 2021, with reference to Movement in Price. The reply is awaited.
The Exchange has sought clarification from Pharmaids Pharmaceut..
27Sep09-27-2021$Pharmaids Pharmaceuticals informs about voting results Pharmaids Pharmaceuticals in

In furtherance to letter dated 20th August 2021, informing the date of Annual General Meeting (AGM) being held as under and the Cut-off date for e-Voting respectively, Pharmaids Pharmaceuticals has informed that the Voting Results (Consolidated: Remote e-Voting and e-Voting during the AGM) on the Resolutions forming part of the Notice of the 32nd AGM of the Company held on Saturday, 25th September 2021 at 12.00 pm through Video Conferencing, pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. All the resolutions were duly passed at the AGM with requisite majority. The company has also enclosed a copy of the consolidated report dated 27th September 2021 of Kashinath Sahu (Certificate of practice no: 4807) of Kashinath Sahu & Co. Practicing Company Secretary/ Scrutiniser on Remote E-voting and the E-voting at the aforesaid AGM.

The above information is a part of company’s filings submitted to BSE.

In furtherance to letter dated 20th August 2021, informing the..
25Sep09-25-2021$Pharmaids Pharmaceuticals informs about proceedings of AGM Pharmaids Pharmaceuticals in

Pharmaids Pharmaceuticals has informed that the 32nd AGM of the Company was held on 25th September’ 2021 through Video Conferencing (‘VC’)/ Other Audio-Visual Means (‘OAVM’) at 12:00 pm IST. In this regard, Pharmaids Pharmaceuticals has informed that the summary of the proceedings of the AGM of the Company. The Voting Results of the 32nd Annual General Meeting of the Company along with the Scrutinizer’s Report will be shared shortly and shall be placed on the Company’s website. The 32nd Annual General Meeting of the Company was concluded at 12:25 pm IST.

The above information is a part of company’s filings submitted to BSE.


Pharmaids Pharmaceuticals has informed that the 32nd AGM of the..
15May05-15-2021$Pharmaids Pharmaceuticals informs about board meeting Pharmaids Pharmaceuticals in

Pursuant to Regulation 29 and 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Pharmaids Pharmaceuticals has informed that the Board of Directors of the Company is scheduled to be held Monday, May 24, 2021 to consider the following business: Approval of audited financial results for the quarter and year ended 31.03.2021 and any Other matter with the permission of the Chair. Further, in accordance with its letter dated 31st March, 2021 the Trading window shall remain closed till 48 hours after communication of aforesaid Financial Results to the Stock Exchange.

The above information is a part of company’s filings submitted to BSE.


Pursuant to Regulation 29 and 47 of the SEBI (Listing Obligatio..
Financials More
Rs. in Millions
QTR Jun 21 ANNUAL 21
Net Profit0.1000000000000010.929999999999998
Gross Profit 0.420000000000001 0.879999999999998
Operating Profit 0.4600000000000011.33
Net Sales 23.4185.51
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Adani Transmission (BSE)
 1858.90 (3.40%)
M.Cap ( in Cr)
204443.70
Thacker & Co (BSE)
 315.00 (4.62%)
M.Cap ( in Cr)
34.26
Vivanza Biosciences (BSE)
 188.15 (4.97%)
M.Cap ( in Cr)
75.26
Anand Rayons (BSE)
 155.05 (4.98%)
M.Cap ( in Cr)
232.34
Grandeur Products (BSE)
 153.70 (3.78%)
M.Cap ( in Cr)
386.63
Shareholding Pattern More
PROMOTERS 65.65 %
NON-INSTITUTION 34.35 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes